Oral semaglutide shows promising results for type 2 diabetes in routine clinical settings

FHS
May 28, 2024
1:27 pm

Semaglutide and its effects on glycemic control, body weight (BW), and tolerability in routine clinical practice.

U.S. veterans’ study reveals key insights into Long COVID and protective role of vaccination

Study examines the clinical characteristics and trends of post-COVID-19 condition (PCC) in U.S. veterans, showing the protective effect of vaccination and the need for precise

December 13, 2023

Recent advances in injectable hydrogel-mediated myocardial infarction therapy

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Myocardial infarction (MI) triggers adverse remodeling mechanisms, thus leading to heart failure.

March 12, 2024

University of Manchester’s new publication offers insight on causes and challenges of poor mental health

The University of Manchester has marked World Mental Health Day today (10 October) with the launch of a new publication offering insight on the causes

October 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.